Cre toxicity in mouse models of cardiovascular physiology and disease

Victoria S Rashbrook1, James T Brash1, Christiana Ruhrberg1

  • 1UCL Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK.

PubMed

Insights

Cre recombinase activity can harm cells, independent of gene editing. Researchers recommend controls for Cre toxicity in cardiovascular studies using the Cre-LoxP system in mice.

Area of Science:

  • Cardiovascular Biology
  • Genetics
  • Molecular Biology

Background:

  • The Cre-LoxP system is crucial for genetic research in mice, particularly for studying cardiovascular development and disease.
  • Engineered mouse models utilize Cre-LoxP for cell-specific gene targeting within the cardiovascular system.

Purpose of the Study:

  • To review existing evidence of Cre recombinase toxicity in cardiovascular research.
  • To outline proposed mechanisms underlying Cre toxicity.
  • To emphasize the need for controls against Cre toxicity in cardiovascular studies.

Main Methods:

  • Literature review of published studies on Cre toxicity.
  • Analysis of mechanisms contributing to Cre-induced cellular stress.

Main Results:

  • Accumulating evidence indicates Cre activity can be toxic to cells, irrespective of its DNA recombination function.
  • Specific examples of Cre toxicity in cardiovascular-relevant cells and tissues are documented.
  • Proposed mechanisms for Cre toxicity include off-target effects and cellular stress responses.

Conclusions:

  • Cre toxicity is a significant consideration in Cre-LoxP based cardiovascular research.
  • Studies using Cre-LoxP in the cardiovascular system should implement controls to mitigate or account for Cre toxicity.
  • Further research into Cre toxicity mechanisms may improve the reliability of genetic studies in cardiovascular biology.